Kolexia
Penel Nicolas Oncologie médicale
Penel Nicolas
Oncologie médicale
Centre Oscar-Lambret
Lille, France
642 Activités
479 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Métastase tumorale Tumeurs des tissus mous Carcinomes Fibromatose agressive Récidive tumorale locale Léiomyosarcome Tumeurs de la prostate Fibrome

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Bompas Emmanuelle
Bompas Emmanuelle
Institut de cancérologie de l'Ouest, Saint-Herblain, France

Industries

Voir plus
MSD
6 collaboration(s)
Dernière en 2023
AstraZeneca
4 collaboration(s)
Dernière en 2023
IMMUNOCORE IRELAND LTD
2 collaboration(s)
Dernière en 2022
PUBLICLIN
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
SUR-CAN: Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring
Essai Clinique (Centre Oscar-Lambret)   19 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Therapeutic advances in urology   28 février 2024
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158): A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
Essai Clinique (Merck & Co.)   02 février 2024
Vismodegib in Treating Patients With Advanced Chondrosarcomas: A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas
Essai Clinique (National Cancer Institute)   26 janvier 2024
Study of DF1001 in Patients With Advanced Solid Tumors: A Phase I/II, First-In-Human, Multi-Part, Open-Label, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF1001 in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications
Essai Clinique (Dragonfly Therapeutics)   25 janvier 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
Handling missing covariates in observational studies: an illustration with the assessment of prognostic factors of survival outcomes in soft-tissue or visceral sarcomas in irradiated fields (SIF).
Therapeutic advances in medical oncology   19 janvier 2024
OS2006 : Protocole de Traitement Des ostéosarcomes de l'Enfant, de l'Adolescent et de l'Adulte Comportant
Essai Clinique (Chugai)   09 janvier 2024